Weekly Recap | 10X Genomics +2.42%, most brokers rate it buyWeekly Review·Oct 24, 2026 at 07:10 AMTXG+1.97%
Weekly Recap | 10X Genomics -13.38%, consensus target above spotWeekly Review·Oct 17, 2026 at 08:19 AMTXG+1.97%
Weekly Recap | 10X Genomics -13.74%, CEO sale meets overvaluation warningWeekly Review·Oct 10, 2026 at 07:57 AMTXG+1.97%
Weekly Recap | 10X Genomics +9.09%, price above most broker targetsWeekly Review·Oct 3, 2026 at 07:55 AMTXG+1.97%
Weekly Recap | 10X Genomics +11.89%, closing in on record highsWeekly Review·Sep 26, 2026 at 07:11 AMTXG+1.97%
Weekly Recap | 10X Genomics +11.68%, consensus target below spotWeekly Review·Sep 19, 2026 at 06:56 AMTXG+1.97%
Weekly Recap | 10X Genomics +9.48%, insider selling alongside the rallyWeekly Review·Sep 12, 2026 at 06:56 AMTXG+1.97%
Weekly Recap | 10X Genomics +1.8%, most brokers rate it buyWeekly Review·Sep 5, 2026 at 08:20 AMTXG+1.97%
Weekly Recap | 10X Genomics -5.5%, most brokers rate it buyWeekly Review·Aug 29, 2026 at 06:33 AMTXG+1.97%
Weekly Recap | 10X Genomics +16.1%, closing in on record highsWeekly Review·Aug 22, 2026 at 05:53 AMTXG+1.97%
